AI/Digital
AI first: novel drug target and novel molecule discovered
One step closer to senescence moonshot: Insilico claims industry first by nominating preclinical candidate for IPF, with both novel...
Integrated nutrition platform for biohacking longevity
Span combines your data and 3rd party apps with expert guidance to boost longevity through biohacking personalised nutrition.
British start-up Span is on a mission...
Skin patch reads both cardiovascular and metabolic biomarkers
UC San Diego researchers create the first wearable device for simultaneous monitoring of haemodynamic and biochemical biomarkers.
Biohackers take note! Engineers at the University of...
Latest news
2021 hits the longevity ground running
Highlights from longevity research, trials and funding in January 2021
Hundreds of companies are working to develop treatments to slow down aging and increase healthy...
AI fast-tracks human longevity extension
Top longevity leaders frame how next-gen AI can extend lifespan.
Deep Longevity, which specialises in the development and the application of next-generation AI for aging...
Going deeper on ketone analysis for longevity
BIOSENSE CEO shares how deep lung samples deliver a better measure of ketosis and fat metabolism.
Linked with several longevity benefits, ketosis is a metabolic...
Proving the Longevity potential of spermidine
Longevity Labs+ seeks to validate efficacy of spermidine supplement through clinical studies; aspires to become the Red Bull of Longevity supplements.
The home of famous...
Clearance of senescent cells for improved cognition
Mayo Clinic proof-of-concept study shows that removal of senescent cells in the hippocampus of mice leads to improved cognitive responses.
It is no secret that...
AI fast-tracks human longevity extension
Top longevity leaders frame how next-gen AI can extend lifespan.
Deep Longevity, which specialises in the development and the application of next-generation AI for aging...
Longevity Escape Velocity within 10 years?
Bestselling book enters new markets and predicts Longevity Escape Velocity by 2029/30.
Back in the 1980s, pop sensation Wham! encouraged us all to "Choose Life";...
AI to quantify senescent cell counts
A long-awaited AI approach can now be implemented in screening for anti-senescence drug candidates.
Developing a novel therapeutic drug can cost between $161 million and...
Study linking heart health to brain health could delay dementia
Oxford University targets arterial stiffening earlier in a person’s lifespan for age-related cognitive benefit and dementia delay.
A new study from the University of Oxford...
Nano drug-delivery system developed for neurological disorders
Unprecedented siRNA penetration across the blood brain barrier in mice could aid therapy for variety of human neurological disorders.
Previous research has identified biological pathways...
Longevity companies to watch in 2021
As the world enters the new year with a vaccine and an increased focus on geroprotection, there’s much to look forward to.
Research from the...
Rise of the superagers – sharp minds and youthful cognition
Superagers retain exceptional memory performance, surpassing the performance of individuals aged 20 years younger.
Age represents a risk for cognitive decline, that increases with advanced...
A year in Longevity: progress perspectives
2020's journey to extending healthy human longevity.
The journey to Longevity has many stages, whether it's a clinical pipeline, gaining regulatory approval for a drug,...
Most popular
AI-enabled doctors will specialise in longevity medicine
We explore what this paper will mean for longevity, with exclusive insights from the authors.
In January 2021 a paper entitled Artificial Intelligence in Longevity Medicine...
Integrated nutrition platform for biohacking longevity
Span combines your data and 3rd party apps with expert guidance to boost longevity through biohacking personalised nutrition.
British start-up Span is on a mission...
Longevity companies to watch in 2021
As the world enters the new year with a vaccine and an increased focus on geroprotection, there’s much to look forward to.
Research from the...
AI first: novel drug target and novel molecule discovered
One step closer to senescence moonshot: Insilico claims industry first by nominating preclinical candidate for IPF, with both novel drug target and novel molecule...
You might also like
Swiss longevity company builder launches
Swiss-based Maximon already moving forward with companies focused on precision supplements and personalised longevity advice.
Already touted as a hotbed of longevity innovation, Switzerland is...
OneSkin: turning back time for your skin
Skin rejuvenating cream goes more than skin deep with senotherapeutic treatment.
Last year we reported on the launch of OneSkin, a topical senotherapeutic skin treatment...
New aging clock is a key longevity tool
A new aging clock that's close to the theoretical limit of accuracy boasts unprecedented precision and offers new insights into how the aging process...
Longeveron completes longevity clinical trial
Longeveron announces successful completion of phase 2b clinical study of Lomecel-B infusion to treat aging frailty.
Longeveron Inc, a clinical stage biotechnology company developing cellular...
Plastic surgery in-a-box: a cryo biotech innovation
Future-facing Uvence is innovating for the future of your face.
The biotech market is growing, as coverage on Longevity.Technology evidences. The ripples of biotech innovation...
